Original Research
Accepted on 26 Apr 2024
The fibrosis-4 index is a prognostic factor for cholangiocarcinoma patients who received immunotherapy
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 26 Apr 2024
in Cancer Immunity and Immunotherapy
Review
Accepted on 26 Apr 2024
in Cancer Immunity and Immunotherapy
Review
Accepted on 26 Apr 2024
in Cancer Immunity and Immunotherapy
Review
Accepted on 26 Apr 2024
in Cancer Immunity and Immunotherapy
Review
Accepted on 26 Apr 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 26 Apr 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 26 Apr 2024
in Cancer Immunity and Immunotherapy
Correction
Published on 26 Apr 2024
in Cancer Immunity and Immunotherapy
Editorial
Published on 26 Apr 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 26 Apr 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 26 Apr 2024
in Cancer Immunity and Immunotherapy
Review
Published on 26 Apr 2024
in Cancer Immunity and Immunotherapy
Review
Published on 26 Apr 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 25 Apr 2024
in Cancer Immunity and Immunotherapy
Editorial
Accepted on 25 Apr 2024
in Cancer Immunity and Immunotherapy
Review
Accepted on 25 Apr 2024
in Cancer Immunity and Immunotherapy